Evidence map›Paper›PMID 32655851›Full record

ArticleTherapeutic advances in endocrinology and metabolism2020

Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance.

Shihab Kochumon, Ashraf Al Madhoun, Fatema Al-Rashed, Rafaat Azim, Ebaa Al-Ozairi, Fahd Al-Mulla, Rasheed Ahmad

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Differential gene expression in nasal airway epithelium from overweight or obese youth with asthma.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Frontiers in immunology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shihab KochumonImmunology and Microbiology Department, Dasman Diabetes Institute, Dasman, Kuwait.
Ashraf Al MadhounAnimal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman, Kuwait.
Fatema Al-RashedImmunology and Microbiology Department, Dasman Diabetes Institute, Dasman, Kuwait.
Rafaat AzimSchool of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Bahrain.
Ebaa Al-OzairiMedical Division, Dasman Diabetes Institute, Kuwait.
Fahd Al-MullaGenetics and Bioinformatics, Dasman Diabetes Institute, Kuwait, Dasman, Kuwait.
Rasheed AhmadImmunology & Microbiology Department, Dasman Diabetes Institute, AL-Soor Street, P.O. Box 1180 Dasman, Kuwait 15462, Kuwait.ORCID https://orcid.org/0000-0001-5746-0743
Dasman Diabetes Institute · KWRoyal College of Surgeons in Ireland - Bahrain · BH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe CXCL subfamily of chemokines (CXCL9, CXCL10, and CXCL11; angiostatic chemokines) plays a key role in many inflammatory diseases. However, the expression of CXCLs in adipose tissue (AT) during obesity and association of these CXCLs with inflammatory markers and insulin resistance are poorly understood. Therefore, this study aimed to investigate the effects of CXCL gene expression on subcutaneous AT inflammatory markers and insulin resistance.

methodsSubcutaneous-fat biopsies were collected from 59 nondiabetic (lean/overweight/obese) individuals for RNA isolation. Expression levels of AT CXCL and inflammatory markers were determined by quantitative reverse transcriptase polymerase chain reaction (RT-qPCR). Biomedical parameters in the plasma were measured by enzyme-linked

resultsAT CXCL expression was higher in obese compared with lean individuals (

conclusionThese data suggest that the CXCL family members, specifically CXCL10 and CXCL11, are potential biomarkers for the onset of AT inflammation during obesity.

Indexed as

adipose tissueCXCL10CXCL11CXCL9insulin resistancemetabolic inflammationobesity

Identifiers

PMID32655851
PMCPMC7331767
OpenAlexW3039666150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.